Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sempli Farma is the commercial brand of Remedio, an Italian innovative SME focused on medication-adherence services rather than drug discovery. The company provides hardware, software, workflow, and pharmacy-enablement services that repackage oral solid medicines into personalized unit-dose sachets or blisters organized by dosing time. Its model is centered on community pharmacies and residential care settings, helping pharmacists automate, personalize, and track therapy preparation for chronic, polymedicated, and fragile patients. The company appears to operate a hub-and-spoke service network in Italy and offers startup, site-management, and commercialization support to pharmacies adopting its system. Sempli Farma is therefore best characterized as a digital health and pharmacy services company in healthcare operations, not a biotech or therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sempli Farma.